| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |